GeminIQ Website Logo

Viewing AFJK free

Subscribe for full history, 90+ metrics, screener, watchlist...

Aimei Health Technology Co., Ltd.

AFJK

Companies in Blank Checks

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
0000000001
Prepaid Expense Current
0-0000000-
Other Receivables
--------0-
Assets Current
0000000001
Assets Held In Trust Noncurrent
12124545447473727170
Assets
12124545447473727170
Liabilities And Stockhold…
Liabilities Current
Accrued Liabilities Current
0000000000
Other Short Term Borrowings
222110----
Other Liabilities Current
11110000--
Liabilities Current
4332210000
Redeemable Noncontrolling…
Deferred Compensation Liability Classified Noncurr…
1111111111
Liabilities
4433221111
Temporary Equity Carrying Amount Attributable To P…
12124545447473727170
Stockholders Equity
Common Stock Value
0000000000
Retained Earnings Accumulated Deficit
-4-4-3-3-2-1-1-1-0-0
Stockholders Equity
-4-4-3-3-2-1-1-1-0-0
Temporary Equity Par Or Stated Value Per Share
---------0
Temporary Equity Shares Authorized
---------500
Liabilities And Stockholders Equity
12124545447473727170
Temporary Equity Shares Issued
8888877777
Temporary Equity Shares Outstanding
8888877777
Temporary Equity Redemption Price Per Share
11.811.6311.3711.1410.9110.6910.5310.3910.2610.13
Common Stock Par Or Stated Value Per Share
0000000000
Common Stock Shares Authorized
500500500500500500500500500500
Common Stock Shares Issued
2222222222
Shares Outstanding
1111222222
Shares Subject To Mandatory Redemption Settlement …
1144477777

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-60.36%-----------
20251.09%1.09%2.45%0.36%1.07%2.05%182.03%537.64%360.65%-3.45%-38.37%-
20240.19%0.61%0.78%0.38%0.77%1.15%-0.39%0.37%1.02%-0.06%1.39%1.39%
2023---------0.79%1.18%2.73%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.01
0.00
0.01
0.02
0.00
0.04
0.54
1.84
6.13
23.38
Quick Ratio
0.01
0.00
0.00
0.00
0.00
0.03
0.45
1.42
5.28
23.38
Working Capital
-3.50M
-3.37M
-2.75M
-2.17M
-1.68M
-786.61K
-106.89K
93.13K
402.24K
555.88K
Leverage & Debt
Debt to Equity
-1.00
-1.00
-1.01
-1.02
-1.00
-1.02
-1.16
-1.34
-2.67
-5.33
Debt Ratio
0.34
0.34
0.08
0.07
0.05
0.02
0.01
0.01
0.01
0.01
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
0.88
1.05
1.41
1.80
1.54
1.48
1.22
-
-
-
Free Cash Flow Per Share TTM
-0.40
-0.56
-0.72
-0.68
-0.57
-0.39
-0.28
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Growth Metrics
Net Income Growth (1Y)
-53.54%
-58.48%
-33.32%
-
-
-
-
-
-
-
EPS Growth (1Y)
-42.42%
-29.21%
15.15%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
27.69
61.12
8.04
6.20
7.16
7.23
8.58
-
-
-
P/B TTM
-6.08
-15.96
-3.29
-3.90
-5.99
-12.50
-22.69
-29.91
-61.51
-
Market Cap
25.49M
64.77M
11.31M
11.14M
14.18M
18.46M
18.08M
17.85M
17.70M
-
Enterprise Value
25.47M
64.77M
11.30M
11.14M
14.17M
18.43M
17.97M
17.70M
17.28M
-
Calculated Values
Free Cash Flow TTM
-415.70K
-565.10K
-717.00K
-674.84K
-729.33K
-672.29K
-477.16K
-
-
-
Net Debt
-18.52K
-2.93K
-2.98K
-2.14K
-7.35K
-28.21K
-103.56K
-157.51K
-413.75K
-580.72K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-02-11Sale
Owner: Mizuho, Securities Usa Ll…
Title: -
Shares: 150,000
Price/Share: $10.86
Value: $1,629,000.00
Shares Owned: 550,387
Relationship: TenPercentOwner
Ownership: Direct
2023-12-01Purchase
Owner: Aimei, Investment Ltd
Title: -
Shares: 332,000
Price/Share: $10.00
Value: $3,320,000.00
Shares Owned: 1,905,000
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
20.78%
Inst. Shares: 841,011
Shares Outstanding: 4,047,369
2025-12-31
19.35%
Inst. Shares: 783,112
Shares Outstanding: 4,047,369
2025-09-30
92.55%
Inst. Shares: 3,697,866
Shares Outstanding: 3,995,733
2025-06-30
92.94%
Inst. Shares: 3,713,460
Shares Outstanding: 3,995,733
2025-03-31
70.61%
Inst. Shares: 3,641,752
Shares Outstanding: 5,157,440

Aimei Health Technology Co., Ltd. (AFJK) — SEC Financial Statements & Analysis

Aimei Health Technology Co., Ltd. (AFJK) is a blank checks company. Aimei Health Technology Co., Ltd. trades on Nasdaq as: AFJK, AFJKR, AFJKU. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Aimei Health Technology Co., Ltd. reported a Debt-to-Equity ratio of -1.00x, a Price-to-Book (P/B) ratio of -6.08 (TTM), at a market cap of $25.49M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
-1.00x
P/B TTM
-6.08
Market Cap
$25.49M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Aimei Health Technology Co., Ltd. in?

Aimei Health Technology Co., Ltd. (AFJK) operates in the Blank Checks industry.

What is AFJK's market cap?

Aimei Health Technology Co., Ltd. (AFJK) has a market capitalization of $25.49M as of 2026-03-31.

What is AFJK's P/E ratio?

Aimei Health Technology Co., Ltd. (AFJK)'s trailing twelve month P/E ratio is 27.69x as of 2026-03-31.

What exchange does AFJK trade on?

Aimei Health Technology Co., Ltd. (AFJK) trades on the Nasdaq.

Research Faster.
Invest Smarter.

Aimei Health Technology Co., Ltd. (AFJK) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.